BetterLife Pharma (BETRF) News Today → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free BETRF Stock Alerts $0.09 -0.01 (-10.31%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | finanznachrichten.deBetterLife Pharma Inc.: BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001May 14, 2024 | finance.yahoo.comBetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001May 14, 2024 | globenewswire.comBetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001May 3, 2024 | markets.businessinsider.comBetterLife Announces Intent to Complete Private Placement of UnitsMay 3, 2024 | globenewswire.comBetterLife Announces Intent to Complete Private Placement of UnitsMay 1, 2024 | finance.yahoo.comBetterLife Advances BETR-001 IND-enabling StudiesApril 15, 2024 | finanznachrichten.deBloom Burton & Co. Inc.: BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 3, 2024 | finance.yahoo.comBetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001March 4, 2024 | financialpost.comBetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityMarch 4, 2024 | globenewswire.comBetterLife's 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityDecember 18, 2023 | finance.yahoo.comBetterLife Announces Closing of a Private PlacementNovember 30, 2023 | finance.yahoo.comBetterLife Announces Extension of WarrantsNovember 15, 2023 | finance.yahoo.comUS Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD DerivativesNovember 9, 2023 | morningstar.comaTyr Pharma Inc LIFESeptember 14, 2023 | finance.yahoo.comBetterLife Pharma to Host Investors Update Call on September 18, 2023September 12, 2023 | finance.yahoo.comBetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001September 5, 2023 | finance.yahoo.comBetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private PlacementJuly 13, 2023 | finance.yahoo.comBetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private PlacementJune 27, 2023 | finance.yahoo.comBetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD DerivativesJune 22, 2023 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, CanadaJune 9, 2023 | msn.comBetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments ContinueJune 8, 2023 | finance.yahoo.comBetterLife Continues Progress on BETR-001 IND-Enabling StudiesApril 25, 2023 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, CaliforniaApril 24, 2023 | finance.yahoo.comBetterLife Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 20, 2023 | finance.yahoo.comBetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceMarch 29, 2023 | proactiveinvestors.comBetterLife Pharma says BETR-001 drug candidate featured in Drug Discovery & Development articleMarch 29, 2023 | finance.yahoo.comBetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development ArticleMarch 22, 2023 | finance.yahoo.comPromise of BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress ArticleMarch 14, 2023 | finance.yahoo.comCORRECTION -- BetterLife Closes $1,857,143 of Private PlacementMarch 14, 2023 | finance.yahoo.comBetterLife Closes $1,857,143 of Private PlacementMarch 13, 2023 | msn.comPsyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & MoreMarch 10, 2023 | finance.yahoo.comBetterLife Files Amended and Restated Offering Document for Offering of UnitsMarch 9, 2023 | msn.comMood Disorders Could Get An Alternative Treatment With This Next-Gen, Non-Hallucinogenic PsychedelicMarch 9, 2023 | proactiveinvestors.comBetterlife Pharma's reports positive study findings for lead candidate BETR-001March 9, 2023 | finance.yahoo.comBetterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders”March 8, 2023 | finance.yahoo.comBetterLife Announces Pricing of Proposed Offering of UnitsMarch 7, 2023 | finance.yahoo.comBetterLife Announces Offering of UnitsJanuary 26, 2023 | proactiveinvestors.comBetterLife Pharma hires strategic advisory services firm to support development toward clinical trials of its psychedelic compoundsJanuary 26, 2023 | finance.yahoo.comBetterLife Announces Engagement of Bloom Burton Securities Inc. and Provides Summary of 2022 AccomplishmentsDecember 7, 2022 | proactiveinvestors.comBetterLife Pharma closes private placement with help from Negev Capital to fuel clinical programsDecember 2, 2022 | proactiveinvestors.comBetterLife to present BETR-001 preclinical data at the American College of Neuropsychopharmacology meeting in PhoenixDecember 2, 2022 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, ArizonaSeptember 27, 2022 | msn.comPsychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD DerivativesSeptember 27, 2022 | proactiveinvestors.comBetterLife Pharma files comprehensive patent for BETR-001 and other LSD derivativesSeptember 27, 2022 | finance.yahoo.comBetterLife Files Comprehensive Patent for BETR-001 and Other LSD DerivativesSeptember 7, 2022 | proactiveinvestors.comBetterLife Pharma and collaborators to submit key joint research on BETR-001 to publicationSeptember 7, 2022 | finance.yahoo.comBetterLife and Collaborators to Submit Key Joint Research PublicationAugust 24, 2022 | proactiveinvestors.comBetterLife Pharma says new study of LSD validates the cognitive effects of its analog drug BETR-001August 24, 2022 | proactiveinvestors.comBetterLife Pharma says new study on LSD confirms the cognitive effects of its analog drug BETR-001August 24, 2022 | finance.yahoo.comBetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects Get BetterLife Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BETRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… BETRF Media Mentions By Week BETRF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BETRF News Sentiment▼1.110.47▲Average Medical News Sentiment BETRF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BETRF Articles This Week▼30▲BETRF Articles Average Week Get BetterLife Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BETRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NCNA News ADXN News ATHE News MTEM News CMMB News AEZS News GRTX News UPC News GHSI News LTUS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BETRF) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsNext President (Not Trump. Not Biden.)The Freeport Society4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.